Shijiazhuang Huashu Pharmaceutical Corporation (“Huashu” for short) is China’s largest manufacturer of antibiotic APIs including oxytetracycline, doxycycline hydrochloride, neomycin sulfate and avermectin. Founded in 1987, Huashu is a joint-stock company with 2,200 employees, including 700 engineering technicians.
Over the past 20-odd years, Huashu has accumulated the most valuable asset, an outstanding expert team on antibiotic fermentation. Our leadership has always attached great importance to staff training so that our production and quality management can meet with the international standard.
Huashu boasts China’s largest fermentation production capacity. With a total volume of fermentation tanks over 13,000 cubic meters, and unit volume ranging from 60 to 240 cubic meters, as well as the domestic first-class experiment-grade fermentation facilities, Huashu boasts strong capability from product R&D, pilot production to industrialized production.
All our products have obtained GMP Certificate. Huashu also strictly follows GMP rules in terms of workshop design, process and operation to effectively guarantee high-quality products.
Huashu is one of the domestic earliest factories to be approved by FDA. Since 1998, Huashu has been approved by FDA for 5 consecutive times. In 2007, our product oxytetracycline obtained COS Certificate awarded by EDQM.
Huashu has always been committed to environmental protection to be an environmental-friendly factory. Since 2000, Huashu has invested a total of more than 100 million yuan in environmental protection. Our disposal of production wastes has reached the national emission standard. In addition, Huashu has also passed the certification of EHS.
In the core values of “Creditable Operation, Top Quality, Social Contribution”, Huashu has always been the first choice of domestic and international customers.
Over the years, Huashu has been frequently awarded “Contract-honoring & Promise-keeping Enterprise” by the local government. And we also highly value credit.
Over the past 20-odd years, Huashu has accumulated the most valuable asset, an outstanding expert team on antibiotic fermentation. Our leadership has always attached great importance to staff training so that our production and quality management can meet with the international standard.
Huashu boasts China’s largest fermentation production capacity. With a total volume of fermentation tanks over 13,000 cubic meters, and unit volume ranging from 60 to 240 cubic meters, as well as the domestic first-class experiment-grade fermentation facilities, Huashu boasts strong capability from product R&D, pilot production to industrialized production.
All our products have obtained GMP Certificate. Huashu also strictly follows GMP rules in terms of workshop design, process and operation to effectively guarantee high-quality products.
Huashu is one of the domestic earliest factories to be approved by FDA. Since 1998, Huashu has been approved by FDA for 5 consecutive times. In 2007, our product oxytetracycline obtained COS Certificate awarded by EDQM.
Huashu has always been committed to environmental protection to be an environmental-friendly factory. Since 2000, Huashu has invested a total of more than 100 million yuan in environmental protection. Our disposal of production wastes has reached the national emission standard. In addition, Huashu has also passed the certification of EHS.
In the core values of “Creditable Operation, Top Quality, Social Contribution”, Huashu has always been the first choice of domestic and international customers.
Over the years, Huashu has been frequently awarded “Contract-honoring & Promise-keeping Enterprise” by the local government. And we also highly value credit.
